LumiThera Secures Financing to Support Commercial Activities
SEATTLE, March 10, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of a debt financing with Leste Clearway and Serengeti Asset Management.
The combined financing provides $5.5M of capital to support integration, growth, and commercial expansion of the LumiThera Valeda® Light Delivery System for the treatment for dry Age-related Macular Degeneration (AMD), and the Diopsys® Electroretinography (ERG) product line, an established diagnostic and monitoring system that measures the electrical activity of the retina of the eye in response to a light stimulus.
“We are very excited to work with both Leste Clearway and Serengeti,” stated Clark E. Tedford, Ph.D., President and CEO, LumiThera. “These debt partners have the potential to further support commercial expansion of LumiThera’s product lines without typical stockholder dilution and should position the company well for a future Series D round.
About Serengeti Asset Management
Serengeti Asset Management (www.serengeti-am.com) is a value driven credit focused investment firm that provides sophisticated financing solutions to innovative private companies and their shareholders. Serengeti has approximately $1.2B of assets under management.
About Leste Clearway
Clearway (www.lesteclearway.com) is an AI powered venture debt fund that uses proprietary technology to identify and underwrite emerging venture backed technology companies in the US and Canada. Leste group, which partly owns Clearway, has approximately $1.3B of assets under management as of September 2021.
Original Publication: https://www.prnewswire.com/news-releases/lumithera-secures-financing-to-support-commercial-activities-301499789.html?tc=eml_cleartime/
Recent Posts
- Ground-Breaking, Drug-Free, and Clinically Tested BackVive Patch Offers Long-Lasting Relief to Chronic Back Pain Sufferers
- SWIR Vision Systems Announces Acuros GO 6 MP Handheld SWIR Camera
- LumiThera Announces Initiation of EUROLIGHT Registry Study to Evaluate Long-term Benefits of Photobiomodulation (PBM) Treatment using the Valeda® Light Delivery System in Patients with Dry Age-Related Macular Degeneration (AMD)
- SWIR Vision Systems Secures Direct to Phase II SBIR Award for Low-Cost SWIR ALPD Technology
- SWIR Vision Systems Unveils 6.3 MP and 4.2 MP Short Wave Infrared Cameras
Archives
- April 2024
- January 2024
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- October 2020
- September 2020
- August 2020
- July 2020
- April 2020
- February 2020
- January 2020
- September 2019
- June 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- October 2018
- September 2018
- July 2018
- June 2018
- April 2018
- March 2018
- January 2018
- October 2017
- April 2017